Up until a couple of years ago, most large pharmaceutical companies were lining up behind the idea of “beyond-the pill” solutions.

With many hard-to-replace blockbuster drugs coming off patent, ‘beyond-the-pill’ offered the potential of new revenue growth without relying solely on the traditional drug pipeline. Drug companies sensed a potential competitive advantage, by adding devices and services (often leveraging technology) that could support better adherence and so improve patient outcomes.

Download the full article by Rick Harris, Founder, Customer Faithful